---
figid: PMC12236749__ijmm-56-03-05570-g02
figtitle: BMSC-Exos alleviate MIRI
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12236749
filename: ijmm-56-03-05570-g02.jpg
figlink: /pmc/articles/PMC12236749/figure/F3/
number: F3
caption: BMSC-Exos alleviate MIRI. miR-101a-3p, miR-149-5p and let-7c-5p in BMSC-Exos
  can activate the PI3K/AKT signaling pathway or inhibit Faslg, further activating
  the Wnt/β-catenin pathway, enhancing SOD activity and reducing ROS, MDA and LDH
  levels. BMSC-derived exosomal lncRNA A2M-AS1 can target miR-556-5p and upregulate
  XIAP expression, alleviating oxidative damage. BMSC-Exos can also activate the HAND2-AS1/miR-17-5p/Mfn2
  pathway to reduce H/R-induced myocardial injury. miR-98-5p in BMSC-Exos suppresses
  cardiac inflammation by inhibiting TLR4 expression and activating the PI3K/AKT pathway.
  BMSC-derived exosomal miR-25-3p, miR-182 and miR-21-5p can inhibit JAK2/STAT3 and
  TLR4/NF-κB signaling while targeting the TLR4/PI3K/AKT pathway, promoting macrophage
  polarization toward the M2 phenotype. Notably, KLF13 is one of the target genes
  of miR-125a-5p in BMSC-Exos that promotes M2 macrophage polarization, downregulating
  IL-6, IL-1β and TNF-α expression and upregulating IL-10 expression to suppress inflammation
  and improve MIRI. miR-125b, miR-183-5p, miR-486-5p, lncRNA HCP5 and miR-19a in BMSC-Exos
  inhibit SIRT7, FOXO1 and regulate miR-497/IGF1/PI3K/AKT or PTEN/AKT/ERK signaling
  pathways, downregulating Bax, caspase-3, cleaved-caspase-3 and upregulating Bcl-2
  to inhibit MIRI apoptosis. In addition, the lncRNA Mir9-3hg in BMSC-Exos can alleviate
  ferroptosis by downregulating ACSL4 expression and upregulating GPX4 and GSH expression
  through the Pum2/PRDX6 axis. miR-330-3p in BMSC-Exos targets and inhibits BAP1 to
  regulate the SLC7A11/IP3R pathway and suppress mPTP opening, thereby inhibiting
  ferroptosis. BMSC-Exos, bone marrow mesenchymal stem cell-derived exosomes; MIRI,
  myocardial ischemia-reperfusion injury; miR/miRNA, microRNA; PI3K, phosphatidylinositol
  3-kinase; AKT, protein kinase B; Faslg, fas ligand gene; SOD, superoxide dismutase;
  ROS, reactive oxygen species; MDA, malondialdehyde; LDH, lactate dehydrogenase;
  lncRNA, long non-coding RNA; XIAP, X-linked inhibitor of apoptosis protein; Mfn2,
  mitofusin 2 protein; H/R, hypoxia/reoxygenation; TLR4, toll-like receptor 4; JAK2,
  Janus kinase 2; STAT3, signal transducer and activator of transcription 3; NF-κB,
  nuclear factor-κB; KLF13, Krüppel-like transcription factor 13; TNF-α, tumor necrosis
  factor-α; SIRT7, sirtuin 7; FOXO1, forkhead box transcription factor 1; IGF1, insulin-like
  growth factor 1; PTEN, phosphatase and tensin homolog deleted on chromosome ten;
  ERK, extracellular signal-regulated kinase; Bax, Bcl-2 associated X protein; ACSL4,
  Acyl-CoA synthetase long-chain family member 4; GPX4, glutathione peroxidase 4;
  GSH, glutathione; Pum2, RNA-binding protein Pumilio2; PRDX6, peroxiredoxin 6; BAP1,
  BRCA1-associated protein 1; SLC7A11, solute carrier family 7a member 11; IP3R, inositol
  1,4,5-trisphosphate receptor; mPTP, mitochondrial permeability transition pore
papertitle: 'Exosome-mediated crosstalk between the cardiovascular and musculoskeletal
  systems: Mechanisms and therapeutic potential (Review)'
reftext: Qingchen Li, et al. Int J Mol Med. 2025 Sep;56(3).
year: '2025'
doi: 10.3892/ijmm.2025.5570
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: Spandidos Publications
keywords: cardiovascular system | musculoskeletal system | exosome | crosstalk | mechanism
  | clinical application
automl_pathway: 0.9466118
figid_alias: PMC12236749__F3
figtype: Figure
redirect_from: /figures/PMC12236749__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12236749__ijmm-56-03-05570-g02.html
  '@type': Dataset
  description: BMSC-Exos alleviate MIRI. miR-101a-3p, miR-149-5p and let-7c-5p in
    BMSC-Exos can activate the PI3K/AKT signaling pathway or inhibit Faslg, further
    activating the Wnt/β-catenin pathway, enhancing SOD activity and reducing ROS,
    MDA and LDH levels. BMSC-derived exosomal lncRNA A2M-AS1 can target miR-556-5p
    and upregulate XIAP expression, alleviating oxidative damage. BMSC-Exos can also
    activate the HAND2-AS1/miR-17-5p/Mfn2 pathway to reduce H/R-induced myocardial
    injury. miR-98-5p in BMSC-Exos suppresses cardiac inflammation by inhibiting TLR4
    expression and activating the PI3K/AKT pathway. BMSC-derived exosomal miR-25-3p,
    miR-182 and miR-21-5p can inhibit JAK2/STAT3 and TLR4/NF-κB signaling while targeting
    the TLR4/PI3K/AKT pathway, promoting macrophage polarization toward the M2 phenotype.
    Notably, KLF13 is one of the target genes of miR-125a-5p in BMSC-Exos that promotes
    M2 macrophage polarization, downregulating IL-6, IL-1β and TNF-α expression and
    upregulating IL-10 expression to suppress inflammation and improve MIRI. miR-125b,
    miR-183-5p, miR-486-5p, lncRNA HCP5 and miR-19a in BMSC-Exos inhibit SIRT7, FOXO1
    and regulate miR-497/IGF1/PI3K/AKT or PTEN/AKT/ERK signaling pathways, downregulating
    Bax, caspase-3, cleaved-caspase-3 and upregulating Bcl-2 to inhibit MIRI apoptosis.
    In addition, the lncRNA Mir9-3hg in BMSC-Exos can alleviate ferroptosis by downregulating
    ACSL4 expression and upregulating GPX4 and GSH expression through the Pum2/PRDX6
    axis. miR-330-3p in BMSC-Exos targets and inhibits BAP1 to regulate the SLC7A11/IP3R
    pathway and suppress mPTP opening, thereby inhibiting ferroptosis. BMSC-Exos,
    bone marrow mesenchymal stem cell-derived exosomes; MIRI, myocardial ischemia-reperfusion
    injury; miR/miRNA, microRNA; PI3K, phosphatidylinositol 3-kinase; AKT, protein
    kinase B; Faslg, fas ligand gene; SOD, superoxide dismutase; ROS, reactive oxygen
    species; MDA, malondialdehyde; LDH, lactate dehydrogenase; lncRNA, long non-coding
    RNA; XIAP, X-linked inhibitor of apoptosis protein; Mfn2, mitofusin 2 protein;
    H/R, hypoxia/reoxygenation; TLR4, toll-like receptor 4; JAK2, Janus kinase 2;
    STAT3, signal transducer and activator of transcription 3; NF-κB, nuclear factor-κB;
    KLF13, Krüppel-like transcription factor 13; TNF-α, tumor necrosis factor-α; SIRT7,
    sirtuin 7; FOXO1, forkhead box transcription factor 1; IGF1, insulin-like growth
    factor 1; PTEN, phosphatase and tensin homolog deleted on chromosome ten; ERK,
    extracellular signal-regulated kinase; Bax, Bcl-2 associated X protein; ACSL4,
    Acyl-CoA synthetase long-chain family member 4; GPX4, glutathione peroxidase 4;
    GSH, glutathione; Pum2, RNA-binding protein Pumilio2; PRDX6, peroxiredoxin 6;
    BAP1, BRCA1-associated protein 1; SLC7A11, solute carrier family 7a member 11;
    IP3R, inositol 1,4,5-trisphosphate receptor; mPTP, mitochondrial permeability
    transition pore
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - A2M
  - IGHA2
  - PTGDR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - FASLG
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - XIAP
  - HAND2-AS1
  - MFN2
  - MIR17
  - TLR4
  - MIR182
  - STAT3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - KLF13
  - SIRT7
  - FOXO1
  - MIR19A
  - IGF1
  - MIR497
  - EPHB2
  - MAPK1
  - MAPK3
  - LDHA
  - LDHB
  - LDHC
  - SOD1
  - IL6
  - IL1A
  - IL1B
  - TNF
  - BAX
  - BLCAP
  - CHMP2A
  - PTEN
  - PUM2
  - PRDX6
  - PRDX5
  - MIR9-3HG
  - SLC7A11
  - BAP1
  - RNF2
  - MAGI1
  - ACSL4
  - ITPR1
  - ITPR3
  - ROS
  - MDA
  - TNF-a
  - mPTP
  - ischemia
---
